المؤلفون: van Muijen ME; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox, 9101, 6500 HB, Nijmegen, The Netherlands. Marloes.vanMuijen@radboudumc.nl.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands. Marloes.vanMuijen@radboudumc.nl., Atalay S; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox, 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., van Vugt LJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox, 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Vandermaesen LMD; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox, 9101, 6500 HB, Nijmegen, The Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox, 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox, 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Radboud University, Nijmegen, The Netherlands.

المصدر: Drugs - real world outcomes [Drugs Real World Outcomes] 2021 Jun; Vol. 8 (2), pp. 163-172. Date of Electronic Publication: 2021 Mar 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE

المؤلفون: Atalay S; Department of Dermatology, Radboud University Medical Center, 6500HB Nijmegen, The Netherlands., van der Schoot LS, Vandermaesen L, van Vugt LJ, Eilander M, van den Reek JMPA, de Jong EMGJ

المصدر: Acta dermato-venereologica [Acta Derm Venereol] 2021 May 25; Vol. 101 (5), pp. adv00463. Date of Electronic Publication: 2021 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-2057 (Electronic) Linking ISSN: 00015555 NLM ISO Abbreviation: Acta Derm Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products*/adverse effects , Psoriasis*/diagnosis , Psoriasis*/drug therapy, Adalimumab/adverse effects ; Drug Tapering ; Etanercept/adverse effects ; Humans ; Prospective Studies ; Ustekinumab/adverse effects

المؤلفون: van Winden MEC; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van der Schoot LS; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van de L'Isle Arias M; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van Vugt LJ; Department of Dermatology, Maastricht University Medical Center, Maastricht, the Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Lubeek SFK; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.

المصدر: JAMA dermatology [JAMA Dermatol] 2020 Nov 01; Vol. 156 (11), pp. 1229-1239.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*administration & dosage , Dermatologic Agents/*administration & dosage , Psoriasis/*drug therapy, Age Factors ; Aged ; Biological Products/adverse effects ; Dermatologic Agents/adverse effects ; Humans ; Psoriasis/diagnosis ; Psoriasis/immunology ; Remission Induction/methods ; Severity of Illness Index ; Treatment Outcome

المؤلفون: Atalay S; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., van Vugt LJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Njoo MD; Department of Dermatology, Ziekenhuis Groep Twente, Hengelo, the Netherlands., Mommers JM; Department of Dermatology, Sint Anna Ziekenhuis, Geldrop, the Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuis Groep Twente, Almelo, the Netherlands., Koetsier MI; Department of Dermatology, Gelre ziekenhuizen, Apeldoorn, the Netherlands., Berends MA; Department of Dermatology, Slingelandziekenhuis, Doetinchem, the Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Groenewoud HMM; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., Kievit W; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.

المصدر: JAMA dermatology [JAMA Dermatol] 2020 Apr 01; Vol. 156 (4), pp. 393-400.

نوع المنشور: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab/*administration & dosage , Dermatologic Agents/*administration & dosage , Etanercept/*administration & dosage , Psoriasis/*drug therapy , Ustekinumab/*administration & dosage, Adult ; Aged ; Biological Products/administration & dosage ; Drug Tapering ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Prospective Studies ; Psoriasis/pathology ; Quality of Life ; Severity of Illness Index ; Treatment Outcome

المؤلفون: van Vugt LJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Meulewaeter E; Department of Dermatology, Ghent University Hospital, Ghent, Belgium., Hakobjan M; Department of Human Genetics, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Heddes N; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Traks T; Department of Dermatology, University of Tartu, Tartu, Estonia.; Department of Dermatology, Tartu University Hospital, Tartu, Estonia., Kingo K; Department of Dermatology, University of Tartu, Tartu, Estonia.; Department of Dermatology, Tartu University Hospital, Tartu, Estonia., Galluzzo M; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy., Talamonti M; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy., Lambert J; Department of Dermatology, Ghent University Hospital, Ghent, Belgium., Coenen MJH; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Department of Human Genetics, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Radboud University, Nijmegen, The Netherlands.

المصدر: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2020 Jan; Vol. 34 (1), pp. 112-118. Date of Electronic Publication: 2019 Aug 05.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Dermatologic Agents/*therapeutic use , Interleukin-17/*genetics , Psoriasis/*drug therapy , Psoriasis/*genetics, Adult ; Cohort Studies ; Europe ; Female ; Genetic Variation/genetics ; Humans ; Male ; Middle Aged ; Open Reading Frames/genetics ; Pharmacogenomic Testing ; Treatment Outcome ; Untranslated Regions/genetics

المؤلفون: van Vugt LJ; Department of Dermatology, Radboud University Medical Centre, Radboud Institute of Health Sciences, Nijmegen, the Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre, Radboud Institute of Health Sciences, Nijmegen, the Netherlands., Hannink G; Department of Operating Rooms, Radboud University Medical Centre, Radboud Institute of Health Sciences, Nijmegen, the Netherlands., Coenen MJH; Department of Human Genetics, Radboud University Medical Centre, Radboud Institute of Health Sciences, Nijmegen, the Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre, Radboud Institute of Health Sciences, Nijmegen, the Netherlands.; Radboud University, Nijmegen, the Netherlands.

المصدر: JAMA dermatology [JAMA Dermatol] 2019 Jun 01; Vol. 155 (6), pp. 708-715.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: HLA-C Antigens/*genetics , Psoriasis/*drug therapy , Ustekinumab/*therapeutic use, Dermatologic Agents/therapeutic use ; Genotype ; Humans ; Psoriasis/genetics ; Randomized Controlled Trials as Topic ; Treatment Outcome

المؤلفون: van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands. Juul.vandenReek@Radboudumc.nl., van Vugt LJ, van Doorn MBA, van der Kraaij GE, de Kort WJA, Lucker GPH, Horvath B, Njoo MD, Bovenschen HJ, Ossenkoppele PM, De Bruin-Weller MS, de Groot M, Mommers R, Prevoo RLMA, van de Kerkhof PCM, Spuls PI, Kievit W, de Jong EMGJ

المصدر: Acta dermato-venereologica [Acta Derm Venereol] 2018 Jul 11; Vol. 98 (7), pp. 648-654.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Print Cited Medium: Internet ISSN: 1651-2057 (Electronic) Linking ISSN: 00015555 NLM ISO Abbreviation: Acta Derm Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Dermatologic Agents/*therapeutic use , Psoriasis/*drug therapy, Adult ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Dermatologic Agents/adverse effects ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Netherlands ; Proportional Hazards Models ; Psoriasis/diagnosis ; Psoriasis/immunology ; Retrospective Studies ; Time Factors ; Treatment Outcome

المؤلفون: van Vugt LJ; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences (RIHS), Nijmegen, the Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences (RIHS), Nijmegen, the Netherlands., Coenen MJH; Radboud Institute for Health Sciences (RIHS), Nijmegen, the Netherlands.; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences (RIHS), Nijmegen, the Netherlands.; Radboud University, Nijmegen, the Netherlands.

المصدر: The British journal of dermatology [Br J Dermatol] 2018 Jan; Vol. 178 (1), pp. 86-94. Date of Electronic Publication: 2017 Dec 14.

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*therapeutic use , Dermatologic Agents/*therapeutic use , Psoriasis/*drug therapy, Adalimumab/therapeutic use ; Cohort Studies ; Etanercept/therapeutic use ; Genome-Wide Association Study ; Humans ; Infliximab/therapeutic use ; Meta-Analysis as Topic ; Pharmacogenomic Testing ; Polymorphism, Genetic ; Psoriasis/genetics ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Tumor Necrosis Factor-alpha/genetics ; Ustekinumab/therapeutic use

المؤلفون: van Vugt LJ; Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Lieke.vanVugt@Radboudumc.nl., van der Vleuten CJM; Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Carine.vanderVleuten@Radboudumc.nl., Flucke U; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Uta.Flucke@Radboudumc.nl., Blokx WAM; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Willeke.Blokx@Radboudumc.nl.

المصدر: Pathology, research and practice [Pathol Res Pract] 2017 Jun; Vol. 213 (6), pp. 591-597. Date of Electronic Publication: 2017 Apr 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Gustav Fischer Verlag Country of Publication: Germany NLM ID: 7806109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-0631 (Electronic) Linking ISSN: 03440338 NLM ISO Abbreviation: Pathol Res Pract Subsets: MEDLINE

مواضيع طبية MeSH: Glucose Transporter Type 1/*metabolism , Hemangioma/*diagnosis , Skin/*metabolism , Skin Neoplasms/*diagnosis, Biomarkers, Tumor/metabolism ; Hemangioma/metabolism ; Hemangioma/pathology ; Humans ; Skin/pathology ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology

المؤلفون: Atalay S; Department of Dermatology, Radboud University Medical Center, Rene Descartesdreef 1, 6525 GL, Nijmegen, The Netherlands. Selma.Atalay@radboudumc.nl., van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Rene Descartesdreef 1, 6525 GL, Nijmegen, The Netherlands., van Vugt LJ; Department of Dermatology, Radboud University Medical Center, Rene Descartesdreef 1, 6525 GL, Nijmegen, The Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Rene Descartesdreef 1, 6525 GL, Nijmegen, The Netherlands., van de Kerkhof PCM; Department of Dermatology, Radboud University Medical Center, Rene Descartesdreef 1, 6525 GL, Nijmegen, The Netherlands., den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Hengstdal 3, 6574 NA, Ubbergen, Nijmegen, The Netherlands., Kievit W; Department for Health Evidence, Radboud University, Geert Grooteplein 21, 6525 EZ, Nijmegen, The Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Center, Rene Descartesdreef 1, 6525 GL, Nijmegen, The Netherlands.; Radboud University, Comeniuslaan 4, 6525 HP, Nijmegen, The Netherlands.

المصدر: BMC dermatology [BMC Dermatol] 2017 May 08; Vol. 17 (1), pp. 6. Date of Electronic Publication: 2017 May 08.

نوع المنشور: Equivalence Trial; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968541 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-5945 (Electronic) Linking ISSN: 14715945 NLM ISO Abbreviation: BMC Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*administration & dosage , Dermatologic Agents/*administration & dosage , Psoriasis/*drug therapy, Adalimumab/administration & dosage ; Administration, Topical ; Adult ; Analysis of Variance ; Cost-Benefit Analysis ; Dose-Response Relationship, Drug ; Etanercept/administration & dosage ; Humans ; Research Design ; Severity of Illness Index ; Ustekinumab/administration & dosage